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The KE family is a large three-generation pedigree in which half the members are affected with a severe speech
and language disorder that is transmitted as an autosomal dominant monogenic trait. In previously published work,
we localized the gene responsible (SPCH1) to a 5.6-cM region of 7q31 between D7S2459 and D7S643. In the
present study, we have employed bioinformatic analyses to assemble a detailed BAC-/PAC-based sequence map of
this interval, containing 152 sequence tagged sites (STSs), 20 known genes, and 17.75 Mb of completed genomic
sequence. We screened the affected chromosome 7 from the KE family with 120 of these STSs (average spacing
!100 kb), but we did not detect any evidence of a microdeletion. Novel polymorphic markers were generated from
the sequence and were used to further localize critical recombination breakpoints in the KE family. This allowed
refinement of the SPCH1 interval to a region between new markers 013A and 330B, containing ∼6.1 Mb of
completed sequence. In addition, we have studied two unrelated patients with a similar speech and language disorder,
who have de novo translocations involving 7q31. Fluorescence in situ hybridization analyses with BACs/PACs from
the sequence map localized the t(5;7)(q22;q31.2) breakpoint in the first patient (CS) to a single clone within the
newly refined SPCH1 interval. This clone contains the CAGH44 gene, which encodes a brain-expressed protein
containing a large polyglutamine stretch. However, we found that the t(2;7)(p23;q31.3) breakpoint in the second
patient (BRD) resides within a BAC clone mapping 13.7 Mb distal to this, outside the current SPCH1 critical
interval. Finally, we investigated the CAGH44 gene in affected individuals of the KE family, but we found no
mutations in the currently known coding sequence. These studies represent further steps toward the isolation of
the first gene to be implicated in the development of speech and language.
Introduction
Between 2% and 5% of children who are otherwise
normal have significant difficulties in acquiring expres-
sive and/or receptive language, despite adequate intel-
ligence and opportunity (Bishop et al. 1995). Strong ev-
idence for genetic influences in developmental disorders
of speech and language was found in a twin study that
showed significant heritability for expressive subtypes of
language impairment, both with and without articula-
tion disorder (Bishop et al. 1995). The vast majority of
Received April 5, 2000; accepted for publication May 31, 2000;
electronically published July 5, 2000.
Address for correspondence: Professor Anthony P. Monaco, The
Wellcome Trust Centre for Human Genetics, University of Oxford,
Roosevelt Drive, Headington, Oxford, OX3 7BN, United Kingdom.
E-mail: anthony.monaco@well.ox.ac.uk
* These authors contributed equally to this study.
 2000 by The American Society of Human Genetics. All rights reserved.
0002-9297/2000/6702-0014$02.00
families segregating such disorders do not follow a sim-
ple Mendelian inheritance pattern, so that the results of
conventional parametric linkage analysis should usually
be viewed with caution.
However, in 1990, Hurst et al. described a rare case
of a large extended family (known as KE) in which the
speech and language disorder is clearly inherited with
an autosomal dominant, monogenic mode of transmis-
sion. Some reports have suggested that the core deficit
of the disorder in this family is an inability to use gram-
matical suffixation rules, such as those for tense, num-
ber, and gender (Gopnik 1990; Gopnik and Crago
1991). Other studies have shown that the phenotype is
not as selective and is characterized by difficulties with
many aspects of grammar and expressive language
(Hurst et al. 1990; Vargha-Khadem and Passingham
1990; Vargha-Khadem et al. 1995, 1998). Furthermore,
the phenotype involves grossly defective articulation
(verbal dyspraxia), such that the speech of affected in-
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Figure 1 Pedigree of family KE, affected by speech and language disorder. Blackened symbols indicate affected individuals. Asterisks
indicate those individuals who were unavailable for linkage analysis.
dividuals is largely incomprehensible to the naive lis-
tener (Hurst et al. 1990; Vargha-Khadem et al. 1995).
In addition, there is evidence of moderate nonverbal
cognitive impairment in some affected family members
(Vargha-Khadem et al. 1995). Recent brain-imaging
studies of affected individuals from this family revealed
functional and structural abnormalities in both cortical
and subcortical motor-related areas of the frontal lobe,
particularly the basal ganglia (Vargha-Khadem et al.
1998). The findings of Vargha-Khadem et al. (1995,
1998) suggest that the central aspect of the disorder
may be the disruption of selection and sequencing of
fine orofacial movements, leading to deficits in the de-
velopment of language skills.
We previously identified a region on chromosome 7
which cosegregates with the speech and language dis-
order in the KE family (maximum LOD score 6.62 at
recombination fraction [v] 0), confirming autosomal
dominant inheritance with full penetrance (Fisher et al.
1998). Fine mapping using all the available Ge´ne´thon
microsatellites from the region allowed us to localize
the gene responsible (termed SPCH1) to a ∼5.6-cM in-
terval of 7q31, flanked by markers D7S2459 and
D7S643 (Fisher et al. 1998). The 7q31 band is well
characterized at the physical level, with extensive cov-
erage in YAC, BAC, and PAC clones (Bouffard et al.
1997). In addition, numerous BAC and PAC clones
from this region are being actively sequenced, as part
of a broader effort to sequence human chromosome 7,
at the Washington University Genome Sequencing Cen-
ter (WU-GSC). Several known genes and a large number
of anonymous expressed-sequence tags (ESTs) have
been mapped to 7q31 by YAC-based or radiation-hy-
brid mapping (Schuler et al. 1996; Bouffard et al. 1997).
In the present study, bioinformatic analyses have been
employed to assemble a detailed BAC-/PAC-based se-
quence map of 7q31, which includes 152 sequence
tagged sites (STSs), 20 known genes, and 50 anonymous
transcripts, thus providing a framework for the posi-
tional cloning of the SPCH1 gene. We have used 120
of these STSs to screen the affected chromosome 7 from
the KE family in a search for microdeletions. In addi-
tion, we have generated novel polymorphic markers
from the sequence and have used these to extract ad-
ditional linkage information from the KE family, in or-
der to refine the SPCH1 interval. Finally, we report the
localization of translocation breakpoints associated
with speech and language disorder in two individuals,
relative to the newly refined SPCH1 critical interval. We
have demonstrated that one of these translocations
maps to the same BAC as the CAGH44 gene, which
encodes a polyglutamine-repeat protein present in
brain, and, therefore, we have investigated this gene
further in the KE family.
Subjects and Methods
Family KE
In 1987, the KE family (see fig. 1) was referred for
genetic counseling by the director of a school for children
with speech and language problems, at which many fam-
ily members had been pupils. The condition was char-
acterized as a developmental verbal dyspraxia (Hurst et
al. 1990).
Patients Bearing Chromosome Translocations
CS is a 5.5-year-old boy with language impairment
and verbal dyspraxia. He has a de novo balanced recip-
rocal translocation t(5;7)(q22;q31.2) which was iden-
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tified prior to his birth via amniocentesis. Examination
at birth showed no abnormalities, but he was referred
back to the genetics team at age 2 years because of con-
cerns of delayed speech and mild motor delay. Subse-
quent assessment at age 3 years 6 mo, performed by
means of the Bailey scale, gave an overall mental de-
velopment in the mildly delayed range. Although non-
verbal skills were in the normal range, there was im-
pairment in both understanding and expression of
speech. A diagnosis was made of oral dyspraxia. By 4
years of age, CS was able to put two words together,
and his understanding had progressed. Fine and gross
motor development had also improved, although there
was still evidence of mild impairment. There is no history
of speech and language disorder in the family of CS, and
none of his siblings (one full sibling and three half-sib-
lings) have any language problems. His mother reports
that he has never been able to laugh spontaneously or
to sneeze.
BRD is an 8-year-old boy with a history of receptive
and expressive language problems, accompanied by be-
havioral difficulties and low-range intellectual abilities,
despite normal physical/motor development. He contin-
ues to show difficulties following verbal instructions in
school, and has word-finding and sequencing problems
accompanied by poor articulation. An MRI scan at age
6 years 11 months detected a small dysembryoplastic
neuroepithelial tumor in his right temporal lobe. A more
detailed description of the clinical phenotype of BRD is
given in Warburton et al. (2000). Cytogenetic analysis
previously revealed a de novo balanced reciprocal trans-
location, t(2;7)(p23;q31.3) (Warburton et al. 2000).
Construction of Human-Hamster Somatic Cell Hybrids
The Chinese hamster mutant cell line a23, deficient in
thymidine kinase, was cultured in 5% CO2 as a mon-
olayer in Dulbecco’s modification of Eagle medium
(DMEM, Life Technologies) supplemented with 10% fe-
tal calf serum (FCS). White cells were separated from
peripheral blood from three affected members of the KE
family (II-2, II-9, and III-20) using Histopaque (Sigma).
Each sample was combined in equal proportions with
trypsinized a23 cells and was placed in serum-free me-
dium. After the cells were spun down, the medium was
aspirated. The cell mixture was resuspended in 50%
polyethylene glycol (PEG, molecular weight 1450,
Sigma), was washed, and was set up in culture with
DMEM and 10% FCS at low cell density. After 24 h,
the culture medium was replaced with the same medium
containing hypoxanthine, aminopterin, and thymidine
(HAT, Life Technologies). Once hybrid colonies reached
2–4 mm in diameter (14 d after fusion), they were picked
into 24-well plates. DNA prepared from samples of
1#105–5#105 cells was tested by PCR for chromosome
7–specific markers.
Genotyping and Linkage Analysis
Primers flanking novel polymorphic repeats were de-
signed using the PRIMER program, accessed through
the United Kingdom Human Genome Mapping Project
resource center. Fluorescence-based semiautomated ge-
notyping was performed as described (Fisher et al.
1998). Linkage analyses were run under the assumption
that the disorder in the KE pedigree is due to a single
autosomal dominant locus with full penetrance, as de-
scribed (Fisher et al. 1998).
Fluorescence In Situ Hybridization (FISH)
PHA-stimulated T lymphocytes or lymphoblastoid
cells lines were harvested by conventional techniques,
and fixed suspensions were dropped onto slides. Slides
were denatured at 70C in 70% formamide/2#SSC for
2 min 30 s, were incubated in cold 2#SSC, and were
serially dehydrated in 70%, 90%, and 100% (twice)
ethanol at room temperature. Probe DNA was labeled
by nick translation with biotin (Gibco BRL BioNick La-
beling System) or Digoxigenin (DIG; Roche) following
manufacturers’ protocols. FISH of BACs and PACs was
performed as described (Millwood et al. 1997). Bioti-
nylated probes were visualized with two layers of FITC-
conjugated streptavidin (green; Vector Labs) and bioti-
nylated goat anti-streptavidin (Vector Labs). DIG-
labeled probes were visualized with mouse anti-DIG an-
tibodies (Roche), followed by Cy5-conjugated rabbit
anti-mouse and goat anti-rabbit antibodies (pseudoco-
lored blue). Chromosomes were counterstained with
Vectorshield containing propidium iodide (Vector Labs).
The slides were viewed on aNikonOptiphot, and images
were captured with a Bio-RadMRC 1024 laser-scanning
confocal microscope and Lasersharp software.
Determination of Genomic Organization of CAGH44
Exon/intron boundaries for exons 1–2 of CAGH44
were identified by comparison of the reported mRNA
sequence (accession U80741) to completed BAC se-
quence. Boundaries for exons 3–6were determinedusing
either long-range PCR or vectorette (Munroe et al.
1994). For the former, we amplified products from hu-
man genomic or BAC DNA, using the Expand Long
Template System (Boehringer Mannheim), with primers
designed from CAGH44 mRNA. Products were se-
quenced using BigDye Terminator Cycle Sequencing kits
(PE Applied Biosystems). For the vectorette method, li-
braries were made by complete digestion of BAC DNA
using frequent-cutting restriction enzymes followed by
ligation to annealed vectorette bubble anchors. Frag-
ments containing exon/intron boundary sequences were
amplified from vectorette libraries by PCR with the
NotI-A primer in combination with specific primers de-
rived from available CAGH44 sequences.
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Figure 2 Sequence map of the D7S2459–D7S643 interval. Previously ordered using YACs, 152 STSs provide a framework for the depicted
BAC-/PAC-based sequence map. The most likely marker order was established by analysis of available genomic sequence data, as described in
the text. For framework markers previously developed from known polymorphisms or genes, the corresponding D7 number or gene name is
given in brackets after the STS name. There are three gaps in the YAC contig map of this interval, indicated by thick vertical lines. Sequence
contigs, assembled using available BAC-/PAC-derived sequence data (represented by black or white circles), are aligned beneath the ordered
STSs. White circles indicate that only “working draft” sequence is currently available for that clone. The prefixes RG, GS, and NH correspond
to BACs derived from the Research Genetics, Genome Systems, and RPCI-11 libraries, respectively; the prefix DJ corresponds to PACs derived
from the RPCI PAC library. Note that each depicted BAC/PAC is associated with a GenBank sequence record and that, in some cases, the clone
contains more DNA than is represented by the sequence record (because of trimming of the sequence to minimize overlaps with adjacent clones).
Many of these sequences can be assembled into large contiguous blocks, as indicated by white rectangles beneath the contigs (with sizes shown
in kb). The positions of 20 known genes are indicated by shaded rectangles. CAGH44 has only been partially characterized, so it is currently
unclear how far it extends relative to the BAC/PAC contigs (indicated by an arrow). Plus signs () below the contigs indicate STSs used for
analysis of hybrid cell lines containing the affected chromosome 7 from family KE. Positions of novel polymorphic markers generated from
sequence data are given above the ordered STSs. Results of linkage analysis of family KE with all polymorphic markers are summarized at the
top of the map: R = recombinant; N = nonrecombinant; U = uninformative. The interval indicated between 013A and 330B is the new critical
region for SPCH1. Within this, all informative markers from 062B to 084A have been shown to cosegregate precisely with the disorder. The
positions of the CS and BRD translocation breakpoints, localised by FISH analysis, are indicated at the bottom of the map.
Results
Construction of a BAC-/PAC-Based Sequence Map
Spanning the SPCH1 Interval of 7q31
Preliminary analysis of chromosome 7 physical-map-
ping data indicated that 152 STSs map to the original
SPCH1 interval, between D7S2459 and D7S643, spe-
cifically within four YAC contigs, designated N, O, P,
and Q (Bouffard et al. 1997). Although many BAC and
PAC clones from this region have been sequenced and
deposited as separate records in the public databases,
much of the sequence information is not fully cross-
referenced and integrated with other related sequences
or with other mapping data. Therefore, we compared
the sequence for all 152 STSs mapping between
D7S2459 and D7S643 to the “non-redundant,” “high-
throughput genome sequence,” andWU-GSC human se-
quencing project-specific databases using the BLAST al-
gorithm (Altschul et al. 1997). At the time of the most
recent analyses (March 2000), 132 of these STSs were
found in fully sequenced BACs/PACs, whereas an ad-
ditional 4 were detected in clones for which partial se-
quence was available. Thus, only 16 STSs were not
found in a sequenced clone.
BLAST analysis of the insert ends of sequenced clones
facilitated the establishment of overlaps among adjacent
clones and orientation of various sequence blocks. These
electronic analyses allowed us to assemble a detailed
BAC-/PAC-based sequence map of 7q31 consisting of
several blocks of contiguous sequence, the largest of
which exceeds 1.5 Mb in length (fig. 2). Within these
sequenced regions, we have been able to accurately de-
termine marker order and intermarker distances. In a
number of cases, the marker order differs from that pre-
viously established in physical-mapping studies. We es-
timate that the D7S2459–D7S643 interval currently
contains 17.75 Mb of completed sequence. No sequence
has been obtained, as yet, from the region covered by
YAC contig P (sWSS1095-sWSS3263), and this region
is estimated from physical mapping studies to span
∼1.25 Mb (Bouffard et al. 1997). Therefore, these anal-
yses indicate that the D7S2459–D7S643 interval is likely
to be 9 Mb in size. Of note, all pairs of adjacent STSs
within assembled sequence blocks are separated by !220
kb.
Transcript Map of 7q31
GeneMap ’99 includes 147 ESTs that have been
mapped to the interval between anchor markers
D7S2459 and D7S480 using radiation-hybrid panels G3
and GB4. Analysis of these ESTs suggested that they
cluster into !96 transcripts, including 18 genes that have
been fully sequenced and/or encode proteins of known
function. Electronic PCR and BLAST searches revealed
that the majority (185%) of the ESTs map to sequenced
BACs/PACs. A total of 50 of the anonymous transcripts
and 13 of the known genes from GeneMap ’99 could
be localized precisely within the D7S2459–D7S643 se-
quence contigs. (Eleven anonymous transcripts and three
known genes are contained in sequenced clones thatmap
proximal or distal to the D7S2459–D7S643 interval; the
remaining 19 transcripts were not found in BAC/PAC
sequences.) An additional six genes not present in the
GeneMap ’99 interval (PDS, LAMB1R, MDG1,
CAGH44, TSA806, and KCND2) were identified and
were localized within the D7S2459–D7S643 contigs via
annotations in BAC/PAC sequence records. Finally, one
of the STSs (sWSS3217) residing within an as-yet-un-
sequenced region was found, by homology screening, to
correspond to the HF.12 gene. Figure 2 shows the rel-
ative positions of all the known genes detected, with
additional summary information provided in table 1.
Search for a 7q31 Microdeletion in Family KE
Previously, cytogenetic analyses of affected members
of the KE family failed to detect any chromosomal ab-
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normality. However, these studies did not rule out a mi-
crodeletion within the SPCH1 interval. We therefore
chose to screen affected individuals for the absence of
STSs within the critical region. This analysis required
the prior separation of the chromosome 7 harboring the
mutation from the normal homologue. Somatic hybrid
cell lines containing human chromosome 7 on a hamster
background were derived from three affected individuals
of the KE family (see Methods). DNA from these cell
lines was genotyped with the Ge´ne´thon markers D7S692
and D7S522, previously shown to be polymorphic in the
affected individuals. In each case, one allele precisely
cosegregates with SPCH1 (Fisher et al. 1998). This al-
lowed identification of hybrid cell lines containing only
an affected chromosome 7, those containing only a nor-
mal chromosome 7, and those containing both copies
of chromosome 7. Hybrid cell lines harboring only the
affected chromosome 7 were tested for the presence of
120 STSs mapping within the D7S2459–D7S643 inter-
val (see fig. 2). The average distance between these STSs
is !100 kb. In all cases, the expected PCR product was
generated from the hybrid cell lines but not fromhamster
DNA controls, indicating that all 120 STSs are present
on the affected chromosome 7 in the KE family.
Generation of Novel Polymorphic Markers in 7q31
and Fine Mapping of the SPCH1 Locus
Our previous linkage study of the KE family with all
the Ge´ne´thon markers from 7q31 identified critical re-
combinations in affected female III-12 and unaffected
male III-3 that defined D7S2459 and D7S643 as prox-
imal and distal limits for SPCH1, respectively (Fisher et
al. 1998) (see fig. 3). Within this ∼5.6-cM region, we
demonstrated that the ∼3.6-cM interval between
D7S692/D7S2425 and CFTR cosegregates perfectly
with the disorder (see figs. 2 and 3). We therefore used
data from the BAC/PAC sequence contigs to develop
novel polymorphic markers from the D7S2459–D7S692
and CFTR–D7S643 intervals, in order to refine further
the positions of the III-12 proximal and III-3 distal re-
combination breakpoints, respectively. Note that the
only Ge´ne´thon markers from these intervals (D7S2456,
D7S655, and D7S2487) were uninformativewith respect
to the disorder in the KE family.
Finished sequence data from these intervals was
searched for stretches of unbroken tandem dinucleotide
repeats with copy numbers of 16, which would be
predicted to be polymorphic (Weber 1990). PCR primers
flanking these repeats were used for semiautomated ge-
notyping of the KE family. The results were analyzed
with parametric linkage programs and haplotypes were
determined as in our previous linkage study. Positions
of new markers relative to the STS map could be ac-
curately established from the sequence data (see fig. 2).
Genotyping with four novel markers at the proximal
end (table 2) revealed that the recombination breakpoint
in individual III-12 maps between 013A and 062B-369B-
369C. This refines the SPCH1 interval by a few hundred
kb at the proximal end, and excludes three known genes
as candidates: PDS, DRA, and DLD (fig. 2). At the dis-
tal end of the SPCH1 interval, physical mapping data
indicated that a polymorphic tetranucleotide repeat,
D7S2847, lies between CFTR and D7S643. Genotyping
of the KE family with D7S2847 demonstrated that the
recombination in individual III-3 maps proximal to this
marker. Investigation of four new markers generated
from the sequence data between CFTR and D7S2847
(table 2) revealed that the III-3 recombination break-
point is localized between 363B-084A and 330B. (084B
was uninformative with respect to the disorder.) This
result excludes a region of 12.65 Mb, containing the
KCND2 gene, from the distal end of the SPCH1 interval.
In addition, it limits the SPCH1 locus to within YAC
contigs N and O, with only one uncloned gap in the
region. Haplotypes of the relevant markers for critical
individuals from the KE family are shown in figure 3.
Two Translocation Breakpoints in 7q31 Associated
with Speech and Language Disorder
We have investigated de novo balanced translocations
involving 7q31 in two unrelated patients with speech
and language disorder, CS 46,XY t(5;7)(q22;q31.2) and
BRD 46,XY t(2;7)(p23;q31.3) (see Subjects and Meth-
ods for clinical descriptions). The 7q31 breakpointswere
localized using two-color FISH to metaphase spreads,
with BACs/PACs selected from proximal and distal ends
of the 7q31 contigs. The breakpoints of both patients
were found to map in the D7S2459–D7S643 interval
(fig. 4), suggesting that the translocations might be rel-
evant to the etiology of speech and language disorder.
Metaphase FISH with a series of further clones iden-
tified from the contigs mapped the CS breakpoint be-
tween RG250D13, which consistently hybridized to the
derivative 7 [der(7)] and RG308B22, which consistently
hybridized to the derivative 5 [der(5)]. Two BACs have
been identified on the basis of fingerprint data to span
the gap between these clones (fig. 2), and these are in
the process of being sequenced. Whereas clone
NH0208M04 mapped to der (5), NH0563O05 gave sig-
nals on both der(7) and der(5), suggesting that this BAC
crosses the 7q31 breakpoint (fig. 4).
A recent study using FISH with YAC clones reported
that the BRD translocation mapped between CFTR and
D7S643 (Warburton et al. 2000). We have been able to
confirm this and to localize the breakpoint at higher
resolution using BAC/PAC clones. These analyses indi-
cate that the BRD breakpoint maps within GS180J15,
which gives signals on both der(7) and der(2) (fig. 4).
Therefore, the 7q31 breakpoints of CS and BRD are
separated by 3.75 Mb of DNA, as estimated from
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Table 1




PDS Pendrin Anion transporter; mutated in Pendred syndrome AF030880
DRA Down-regulated in adenoma Anion transporter; mutated in congenital chlo-
ride diarrhoea
L02785
DLD Dihydrolipoamide dehydrogenase Mitochondrial matrix protein; mutated
in infantile lactic acidosis
NM_000108
LAMB1 Laminin beta-1 chain precursor Component of extracellular matrix M61916
LAMB1R Novel laminin beta-1 related protein Highly similar to LAMB1 AF172277
Bravo-NrCAM Neuronal cell adhesion molecule Implicated in axonal pathfinding in developing
nervous system
NM_005010
MDG1 Microvascular endothelial differentiation
gene 1
Expression of rat homologue increased during
tube-forming process of microvascular endo-
thelial cells
AB026908
HF12 Zinc finger protein Involved in cell differentiation/proliferation X07290
Leu-Rch Rep Leucine-rich repeat protein Possible role in neural development via protein-
protein interactions
AC004142
KIAA0716 Large protein expressed in brain Unknown AB018259
IFRD1 Interferon-related developmental
regulator
Growth factor-sensitive positive regulator of cell
differentiation
Y10313
CAGH44 Polyglutamine repeat protein from brain Long polyglutamine tract containing 40 consecu-
tive glutamines
U80741
CAV2 Caveolin 2 Component of caveolae membranes; upregulated
in response to neuronal cell injury
AF035752
CAV1 Caveolin 1 Component of caveolae membranes; interacts di-
rectly with G-protein alpha subunits
Z18951
MET Hepatocyte growth factor receptor Tyrosine protein kinase; mutated in papillary re-
nal carcinoma
J02958
CAPZA2 F-actin capping protein Binds growing ends of actin filaments; blocks
exchange of subunits
U03269
WNT2 Wingless-type MMTV integration site 2 May be signaling protein affecting development
of discrete regions of tissues
X07876
CFTR Cystic fibrosis transmembrane conduc-
tance regulator
ATP-binding chloride transporter; mutated in
cystic fibrosis
NM_000492
TSA806 Testis-specific ankyrin motif protein Possible role in cell cycle control or cell fate
determination
D78334
KCND2 Brain-specific potassium channel KV4.2 Involved in dendritic spike propagation AF121104
a Figure 2 gives the positions of all these genes.
b Accession numbers are given for the nucleotide sequence of each gene.
completed sequence and the size of YAC contig P (fig.
2). Furthermore, the BRD translocationmaps1.45Mb
distal to the newly refined SPCH1 interval, as established
from the most recent linkage analyses of the KE family
reported above (fig. 2).
Candidate Gene CAGH44, in the Vicinity of the CS
Translocation
CAGH44 mRNA was originally isolated from human
brain in an attempt to identify novel CAG-repeat-con-
taining cDNAs whose expansion might be implicated in
the etiology of neuropsychiatric disorders (Margolis et
al. 1997). The CAGH44 product contains a stretch of
40 consecutive glutamine residues, which is the longest
polyglutamine tract found thus far in an unexpanded
protein. This is encoded by a combination of CAG and
CAA codons, such that there are never more than five
consecutive CAGs. There is a second polyglutamine
stretch, containing only 10 glutamines, encoded by
(CAG)7(CAA)(CAG)(CAA), which is separated from the
first stretch by eight amino acids. Currently, there is only
partial cDNA sequence reported for this gene, covering
912 bases of the coding region, and no information
about its genomic structure.
Although Margolis et al. (1997) previously localized
CAGH44 to 6q14-15 by radiation-hybrid mapping, the
chromosome 7 physical map and sequence data indicates
that, in fact, it resides in 7q31, close to the CS trans-
location breakpoint (fig. 2). Specifically, bioinformatic
analyses found that RG250D13, the BAC hybridizing
to der(7) adjacent to the CS translocation breakpoint,
includes the first 258 bases of the partial CAGH44 cod-
ing sequence, organized into two exons. Analysis of se-
quence data from clones linking RG250D13 to
RG308B22 enabled us to orient the completed
RG250D13 sequence (including the two 5′ CAGH44
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Figure 3 Haplotype analysis of new markers from the D7S2459–D7S643 region limits the SPCH1 interval between 013A and 330B. This
figure shows critical recombinants in unaffected individual III-3 and affected individual III-12. In addition, haplotypes are shown for the affected
parent and for two sibs (one affected, one unaffected) of each of these critical individuals. Numbers used to identify individuals correspond to
those in figure 1. Results from markers D7S2459, D7S523, CFTR, and D7S643 are taken from our previous report (Fisher et al. 1998); the
remaining markers were genotyped in the present study. Haplotypes were inferred from genotype data as described (Fisher et al. 1998). Paternal
haplotypes are on the left, maternal on the right. Boxed areas are used to represent the haplotype that cosegregates with the disorder. Arrows
show the positions of recombination events involving the disease chromosome. All affected members not shown in this figure have inherited
the nonrecombinant disorder-associated haplotype for this region. Two-point LOD score results from linkage analysis of the entire KE pedigree
are given on the right side of this figure. Note that, for this localization of SPCH1, we are assuming that the disorder is fully penetrant.
exons) relative to the sequence contigs. This indicated
that the more 3′ exons of CAGH44 should lie on the
distal side of RG250D13. Using long-range PCR and the
vectorette method on BAC DNA, we were able to con-
firm this and to determine the genomic organization of
the CAGH44 3′ coding region (table 3), thereby dem-
onstrating the presence of four 3′ exons (3, 4, 5, and 6)
in clone NH0563O05, in the interval between
sWSS2794 and sWSS1765. This coincides exactly with
the region containing the CS breakpoint (fig. 2). Bioin-
formatic analysis of genomic sequence from BAC
RG250D13, upstream of the proposedCAGH44 coding
region, confirms that the first ATG in the reported cDNA
sequence is very likely to correspond to the start of the
open reading frame. Therefore, exon 1 is indeed the first
coding exon of this gene, although there may be addi-
tional exons upstream of this containing 5′ untranslated
sequence. However, the ORF probably extends beyond
the 3′ end of the currently reported cDNA sequence,
since no in-frame stop codon has yet been reached. In
addition, our PCR and vectorette analyses indicate that
the last 43 bases (870–912) in the cDNA sequence re-
ported by Margolis et al. (1997) do not come from the
CAGH44 gene, but are likely to be an artifact of the
original cloning procedure. This hypothesis is supported
by the presence of an EcoRI site at 871–876 and by the
observation that bases 878–912 are highly homologous
(94% identity) to human ribosomal protein S16 mRNA.
Given that CAGH44 maps to the same region as the
CS breakpoint and encodes a brain-expressed polyglu-
tamine repeat, we decided to analyze this gene in family
KE. We did not detect any expansion of the regions
encoding the polyglutamine stretches in members of the
family. Furthermore, sequencing of the currently known
CAGH44 coding region did not reveal any variant cos-
egregating with the disorder.
Discussion
Our previous investigation of family KE provided the
first clues to the chromosomal location of a gene in-
volved in speech and language disorder. In the present
work, we have used the extensive bioinformatic re-
sources available to characterize the region of 7q31 that
is likely to contain this gene. A significant proportion of
this interval is represented by sequenced genomic clones;
87% of the framework STSs that map betweenD7S2459
and D7S643 are present within complete BAC or PAC
sequence entries in Genbank. When these separate en-
tries are assembled into large blocks of contiguous se-
quence and are integrated with other mapping data, the
resulting sequence map is a powerful tool for investi-
gating the region of interest, as illustrated here. For ex-
ample, by searching for tandem dinucleotide repeats in
specific intervals of the 7q31 sequence map, we were
able to generate novel polymorphic markers for refined
linkage analyses, allowing us to narrow the SPCH1 in-
terval in family KE by several Mb.
In the absence of additional large families segregating
verbal dyspraxia that might aid the fine mapping of
SPCH1, the study of chromosomal rearrangements such
as those described here provides an alternative means
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Table 2





Forward Reverse BACa KEb
013A (GT)19 RG013F03 CATACTCTCCCGGCCTCAC TGGTCCCACCTTGGTTAAAA 142 138–150
062B (TA)7(CA)21 RG062N11 AGCTTTGAATACTACTGCTGCC TGTATTCAGTGAAGTTGCCATG 191 195–221
369B (CA)21 RG369K23 TGGAAGAGTTTGTGATTTTCAG AGGGTTGTTTATTCAGAGGAGG 281 275–283
369C (CA)18 RG369K23 TAATGTGGTTGAGCTAGGTTGG ACCGAAGAGCCTGAAAACTG 259 259–265
363B (CA)30 RG363I12 GGGACTGCCCAGAGATGAC CCTCTCCAACTTTGCTGACC 308 294–314
084A (CA)20 RG084D04 ACTAGAGTGCTCCCTTCAGCC AAAATAAATTCCCACCCCTATG 302 304–308
084B (CA)25 RG084D04 CTGCTCAAGGCCCATCTTC TTTTTCCATCCGTTTTCTGC 241 233–243
330B (TG)16 RG330P16 CTACCATAATTTCCTCCCTCCC ACCTTCATTCAACTTCCCCC 279 281–293
a Size of the PCR product in bases, as predicted from the BAC sequence.
b Actual size range of the products amplified from the KE family, as determined by fluorescent genotyping.
of narrowing the search for the gene. However, we note
that observation of a breakpoint mapping to the critical
interval in a patient affected with speech and language
disorder does not in itself provide sufficient evidence of
a causal role for the chromosomal abnormality. In ad-
dition, the breakpoint of a chromosomal rearrangement
can sometimes map outside the transcription and pro-
moter regions of the gene implicated in the etiology of
the disease but still disrupt expression of this gene via
a “position effect.” Some studies have demonstrated
position effects acting as far as 900 kb from the gene
responsible for the disorder (see Kleinjan and van Hey-
ningen 1998). Therefore, drawing conclusions from the
mapping of a chromosomal rearrangement can be dif-
ficult, unless they are substantiated by converging data
from multiple cases or other kinds of analysis.
We have demonstrated that, although both the CS
and BRD breakpoints map to 7q31, they are separated
by 13.75 Mb of DNA. Thus, even allowing for the
possibility of position effects, it seems unlikely that these
breakpoints are influencing a single locus and that the
patients have the same disease etiology. The develop-
mental delay of BRD appears to be less selective than
that of CS, involving behavioral problems and some
general cognitive deficit, in addition to his speech and
language difficulties. Warburton et al. (2000) previously
mapped the BRD breakpoint to the CFTR–D7S643 in-
terval and suggested that it may disrupt SPCH1. Our
fine mapping of the BRD translocation, in combination
with the refinement of the critical region from new link-
age analyses of the KE family, indicates that this break-
point in fact maps 11.45Mb outside the current SPCH1
interval. The clone spanning the BRD breakpoint has
been fully sequenced, but no transcripts have been
found by electronic analyses of this sequence. Although
it is possible that the BRD translocation could alter
expression of the brain-specific KCND2 gene, whose
promoter lies a few hundred kb distal to the breakpoint,
our fine-mapping linkage results have excluded that lo-
cus as a candidate for SPCH1. It is worth noting that
BRD has a right temporal lobe tumor, which, by virtue
of its developmental origin, could interfere with the
emergence of cognitive abilities, including those of
speech and language.
In contrast, our analysis of the CS translocation
places it within a single BAC (NH0563O05) inside the
refined SPCH1 critical interval and suggests that it may
disrupt the locus for CAGH44, a brain-expressed gene
encoding a long polyglutamine tract. NH0563O05 is
currently being sequenced and we are in the process of
identifying the exact position of the breakpoint in order
to confirm that the CS translocation does indeed inter-
rupt the CAGH44 coding region. As stated above, fur-
ther evidence will be required to properly establish a
causal role of this breakpoint and the CAGH44 gene
in the speech and language difficulties of CS.
The CAGH44 gene was first identified in a search for
loci encoding polymorphic glutamine repeats whose ex-
pansion might cause neurological diseases (Margolis et
al. 1997). Analysis of the polyglutamine-rich region
showed that it is completely stable in normal individuals
(Margolis et al. 1997), most likely because the CAG
repeats that encode it are frequently interrupted byCAA
codons, suggesting that they are unlikely to undergo the
multistep gradual expansion typically associated with
CAG-repeat disorders. Nevertheless, a recent study has
shown that expansion of an impure CAG repeat (that
of TATA-binding protein) can occur and can lead to a
neurological disease (Koide et al. 1999). Therefore, on
the basis of this and the results from the mapping of
the CS translocation, CAGH44 appears to be a good
candidate for SPCH1.Our mutation analysis of the cur-
rently known coding region for this gene did not detect
expansion of the polyglutamine stretches or, indeed, any
other variants cosegregating with the disorder in family
KE. Since the most 3′ portion of the open reading frame
was not isolated in the Margolis et al. (1997) study, we
are at present identifying and fully characterizing the
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Figure 4 Two-color FISH analyses of translocations in patients with speech and language disorder, using BACs from 7q31. A, Patient
CS; RG250D13 (blue) hybridizes to normal 7 and der(7) and is proximal to the translocation breakpoint, while NH0563O05 (green) hybridizes
to normal 7, der(7) and der(5), spanning the breakpoint. B, Same metaphase as in 4A, with RG250D13 (blue) removed computationally, leaving
only signal from NH0563O05 (green). C, Patient BRD; RG330P16 (blue) hybridizes to normal 7 and der(7), proximal to the breakpoint, while
GS180J15 (green) hybridizes to normal 7, der(7) and der(2), spanning the breakpoint. D, Same metaphase as in 4C with RG330P16 removed
computationally.
CAGH44 gene so that we may investigate it further in
the KE family and in the patient CS.
We previously commented on the fact that the SPCH1
interval overlaps with a ∼40-cM region identified in a
genome screen for susceptibility to autism, a disorder
which is often associated with speech and language ab-
normalities (Fisher et al. 1998; International Molecular
Genetic Study of Autism Consortium 1998). Further
support for a gene influencing autistic disorder on 7q
has been found in additional linkage studies, but regions
of linkage vary between data sets; whereas some show
overlap with SPCH1, others implicate a region distal to
this (Ashley-Koch et al. 1999; Barrett et al. 1999; In-
ternational Molecular Genetic Study of Autism Con-
sortium 1999; Philippe et al. 1999). We, and others,
have identified chromosomal rearrangements (including
translocations, inversions, and a duplication) involving
7q31 in patients with autism (Ashley-Koch et al. 1999;
Vincent et al. 1999; Warburton et al. 2000; C. S. L. Lai,
S. E. Fisher, P. A. Jacobs, E. R. Levy, C. G. Woods, and
A. P.Monaco, unpublished data). However, breakpoints
for these rearrangements map to a number of different
sites, some within the SPCH1 interval and others distal
to it, in a broad region of 7q31. Therefore, no simple
relationship has yet emerged between the positions of
chromosomal breakpoints in 7q and autism or language
disorder. In addition, we note that the severe speech and
language difficulties experienced by family KE are dis-
tinct from those normally associated with autistic dis-
order and that no members of this family have ever
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Table 3
Genomic Organization of CAGH44
Exon 3′ Splice Sitea Exon Sizeb 5′ Splice Sitea BAC Clone Method Usedc
1 168 ACAACAGCAGgtaagttttg RG250D13 GS
2 ttacttctagGCTCTCCAGG 90 ACCACTGCAGgttagtaaag RG250D13 GS
3 tctgtgcaagGTGCCTGTGT 138 GCTGCAGCAGgtaatgtgg NH0563O05 3′: VP / 5′: LP
4 gtttattcagCAACATCTAC 201 AGCGAAAGAGgtaggatccg NH0563O05 LP
5 ctgataccagCAGCAGCAGC 178 CTGCCTCAAGgtacatacaa NH0563O05 3′: LP / 5′: VP
6 cattttatagCTGGCTTAAG 194 NH0563O05 VP
NOTE.—For mutational analysis, primers were designed to flank each of the CAGH44 exons using the genomic
sequence determined here. These were used for PCR amplification of DNA from affected and unaffected individuals
of the KE family, and from the hybrid cell lines containing the affected chromosome 7.
a Exonic sequence is in uppercase, intronic in lowercase.
b Size of exon 1 is estimated from ATG at start of CAGH44 mRNA reported sequence (U80741). Exon 6 is likely
to continue beyond the end of U80741.
c GS = comparison to BAC genomic sequence obtained fromGenbank; VP = vectorette PCR followed by sequencing;
LP = Long-range PCR followed by sequencing.
shown any autistic features. Thus, there is insufficient
evidence from current clinical, cytogenetic, and linkage
data to resolve the issue of whether there is a single
7q31 locus responsible for SPCH1 and autism suscep-
tibility or two separate, adjacent loci contributing in-
dependently to these disorders.
In conclusion, our genomic characterization of the
SPCH1 region has provided a framework for the in-
vestigations of family KE and the translocation patients
presented in this report. These studies represent further
steps towards the isolation of the first gene to be im-
plicated in the development of speech and language.
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